Primary Antibodies

Figure 1.Example of immunocytochemistry staining using a primary antibody, anti-beta-actin antibody.
Primary antibodies play a role in locating, detecting, identifying, and quantifying a target molecule. They directly bind to the antigen protein of interest. Primary antibodies can be produced as polyclonal, monoclonal, or recombinant antibodies.
Explore our wide range of high-quality primary antibodies below.
Need help finding the correct antibody for your application?
Use our Antibody Explorer search tool to view and compare antibodies by clonality, application, species reactivity, conjugate, host species, and form.
Products

Anti-Tyrosine Hydroxylase Antibody
CHEMICON®, rabbit polyclonal

Anti-Choline Acetyltransferase Antibody
CHEMICON®, goat polyclonal

Anti-NeuN Antibody, clone A60
clone A60, Chemicon®, from mouse

Anti-Puromycin Antibody, clone 12D10
clone 12D10, from mouse

Anti-SOX9 Antibody
CHEMICON®, rabbit polyclonal

Anti-Tyrosine Hydroxylase Antibody
CHEMICON®, mouse monoclonal, LNC1

Anti-OLIG2 Antibody
CHEMICON®, rabbit polyclonal

Anti-DNA-RNA Hybrid Antibody, clone S9.6
clone S9.6, from mouse

Anti-GAD67 Antibody
CHEMICON®, mouse monoclonal, 1G10.2

Anti-Glial Fibrillary Acidic Protein Antibody
CHEMICON®, mouse monoclonal, GA5

Anti-GAPDH Antibody
CHEMICON®, mouse monoclonal, 6C5

Anti-NeuN Antibody
rabbit polyclonal

Anti-CSPG4 Antibody
CHEMICON®, rabbit polyclonal

Anti-phospho-Histone H3 (Ser10) Antibody, Mitosis Marker
Upstate®, from rabbit

Anti-Dystrophin Antibody
mouse monoclonal, 2C6 (MANDYS106)

Anti-Vesicular Glutamate Transporter 1 Antibody
CHEMICON®, guinea pig polyclonal

Anti-dsRNA Antibody, clone rJ2
culture supernatant, clone rJ2, from mouse

Anti-NeuN Antibody
serum, from guinea pig

Anti-NeuN Antibody
from chicken, purified by affinity chromatography

Anti-Tyrosine Hydroxylase Antibody
CHEMICON®, sheep polyclonal
- Page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- Page 10
- Page 11
- Page 12
- Page 13
- Page 14
- Page 15
- Page 16
- Page 17
- Page 18
- Page 19
- Page 20
- Page 21
- Page 22
- Page 23
- Page 24
- Page 25
- Page 26
- Page 27
- Page 28
- Page 29
- Page 30
- Page 31
- Page 32
- Page 33
- Page 34
- Page 35
- Page 36
- Page 37
- Page 38
- Page 39
- Page 40
- Page 41
- Page 42
- Page 43
- Page 44
- Page 45
- Page 46
- Page 47
- Page 48
- Page 49
- Page 50
- Page 51
- Page 52
- Page 53
- Page 54
- Page 55
- Page 56
- Page 57
- Page 58
- Page 59
- Page 60
- Page 61
- Page 62
- Page 63
- Page 64
- Page 65
- Page 66
- Page 67
- Page 68
- Page 69
- Page 70
- Page 71
- Page 72
- Page 73
- Page 74
- Page 75
- Page 76
- Page 77
- Page 78
- Page 79
- Page 80
- Page 81
- Page 82
- Page 83
- Page 84
- Page 85
- Page 86
- Page 87
- Page 88
- Page 89
- Page 90
- Page 91
- Page 92
- Page 93
- Page 94
- Page 95
- Page 96
- Page 97
- Page 98
- Page 99
- Page 100
- Page 101
- Page 102
- Page 103
- Page 104
- Page 105
- Page 106
- Page 107
- Page 108
- Page 109
- Page 110
- Page 111
- Page 112
- Page 113
- Page 114
- Page 115
- Page 116
- Page 117
- Page 118
- Page 119
- Page 120
- Page 121
- Page 122
- Page 123
- Page 124
- Page 125
- Page 126
- Page 127
- Page 128
- Page 129
- Page 130
- Page 131
- Page 132
- Page 133
- Page 134
- Page 135
- Page 136
- Page 137
- Page 138
- Page 139
- Page 140
- Page 141
- Page 142
- Page 143
- Page 144
- Page 145
- Page 146
- Page 147
- Page 148
- Page 149
- Page 150
- Page 151
- Page 152
- Page 153
- Page 154
- Page 155
- Page 156
- Page 157
- Page 158
- Page 159
- Page 160
- Page 161
- Page 162
- Page 163
- Page 164
- Page 165
- Page 166
- Page 167
- Page 168
- Page 169
- Page 170
- Page 171
- Page 172
- Page 173
- Page 174
- Page 175
- Page 176
- Page 177
- Page 178
- Page 179
- Page 180
- Page 181
- Page 182
- Page 183
- Page 184
- Page 185
- Page 186
- Page 187
- Page 188
- Page 189
- Page 190
- Page 191
- Page 192
- Page 193
- Page 194
- Page 195
- Page 196
- Page 197
- Page 198
- Page 199
- Page 200
- Page 201
- Page 202
- Page 203
- Page 204
- Page 205
- Page 206
- Page 207
- Page 208
- Page 209
- Page 210
- Page 211
- Page 212
- Page 213
- Page 214
- Page 215
- Page 216
- Page 217
- Page 218
- Page 219
- Page 220
- Page 221
- Page 222
- Page 223
- Page 224
- Page 225
- Page 226
- Page 227
- Page 228
- Page 229
- Page 230
- Page 231
- Page 232
- Page 233
- Page 234
- Page 235
- Page 236
- Page 237
- Page 238
- Page 239
- Page 240
- Page 241
- Page 242
- Page 243
- Page 244
- Page 245
- Page 246
- Page 247
- Page 248
- Page 249
- Page 250
- Page 251
- Page 252
- Page 253
- Page 254
- Page 255
- Page 256
- Page 257
- Page 258
- Page 259
- Page 260
- Page 261
- Page 262
- Page 263
- Page 264
- Page 265
- Page 266
- Page 267
- Page 268
- Page 269
- Page 270
- Page 271
- Page 272
- Page 273
- Page 274
- Page 275
- Page 276
- Page 277
- Page 278
- Page 279
- Page 280
- Page 281
- Page 282
- Page 283
- Page 284
- Page 285
- Page 286
- Page 287
- Page 288
- Page 289
- Page 290
- Page 291
- Page 292
- Page 293
- Page 294
- Page 295
- Page 296
- Page 297
- Page 298
- Page 299
- Page 300
- Page 301
- Page 302
- Page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- Page 10
- Page 11
- Page 12
- Page 13
- Page 14
- Page 15
- Page 16
- Page 17
- Page 18
- Page 19
- Page 20
- Page 21
- Page 22
- Page 23
- Page 24
- Page 25
- Page 26
- Page 27
- Page 28
- Page 29
- Page 30
- Page 31
- Page 32
- Page 33
- Page 34
- Page 35
- Page 36
- Page 37
- Page 38
- Page 39
- Page 40
- Page 41
- Page 42
- Page 43
- Page 44
- Page 45
- Page 46
- Page 47
- Page 48
- Page 49
- Page 50
- Page 51
- Page 52
- Page 53
- Page 54
- Page 55
- Page 56
- Page 57
- Page 58
- Page 59
- Page 60
- Page 61
- Page 62
- Page 63
- Page 64
- Page 65
- Page 66
- Page 67
- Page 68
- Page 69
- Page 70
- Page 71
- Page 72
- Page 73
- Page 74
- Page 75
- Page 76
- Page 77
- Page 78
- Page 79
- Page 80
- Page 81
- Page 82
- Page 83
- Page 84
- Page 85
- Page 86
- Page 87
- Page 88
- Page 89
- Page 90
- Page 91
- Page 92
- Page 93
- Page 94
- Page 95
- Page 96
- Page 97
- Page 98
- Page 99
- Page 100
- Page 101
- Page 102
- Page 103
- Page 104
- Page 105
- Page 106
- Page 107
- Page 108
- Page 109
- Page 110
- Page 111
- Page 112
- Page 113
- Page 114
- Page 115
- Page 116
- Page 117
- Page 118
- Page 119
- Page 120
- Page 121
- Page 122
- Page 123
- Page 124
- Page 125
- Page 126
- Page 127
- Page 128
- Page 129
- Page 130
- Page 131
- Page 132
- Page 133
- Page 134
- Page 135
- Page 136
- Page 137
- Page 138
- Page 139
- Page 140
- Page 141
- Page 142
- Page 143
- Page 144
- Page 145
- Page 146
- Page 147
- Page 148
- Page 149
- Page 150
- Page 151
- Page 152
- Page 153
- Page 154
- Page 155
- Page 156
- Page 157
- Page 158
- Page 159
- Page 160
- Page 161
- Page 162
- Page 163
- Page 164
- Page 165
- Page 166
- Page 167
- Page 168
- Page 169
- Page 170
- Page 171
- Page 172
- Page 173
- Page 174
- Page 175
- Page 176
- Page 177
- Page 178
- Page 179
- Page 180
- Page 181
- Page 182
- Page 183
- Page 184
- Page 185
- Page 186
- Page 187
- Page 188
- Page 189
- Page 190
- Page 191
- Page 192
- Page 193
- Page 194
- Page 195
- Page 196
- Page 197
- Page 198
- Page 199
- Page 200
- Page 201
- Page 202
- Page 203
- Page 204
- Page 205
- Page 206
- Page 207
- Page 208
- Page 209
- Page 210
- Page 211
- Page 212
- Page 213
- Page 214
- Page 215
- Page 216
- Page 217
- Page 218
- Page 219
- Page 220
- Page 221
- Page 222
- Page 223
- Page 224
- Page 225
- Page 226
- Page 227
- Page 228
- Page 229
- Page 230
- Page 231
- Page 232
- Page 233
- Page 234
- Page 235
- Page 236
- Page 237
- Page 238
- Page 239
- Page 240
- Page 241
- Page 242
- Page 243
- Page 244
- Page 245
- Page 246
- Page 247
- Page 248
- Page 249
- Page 250
- Page 251
- Page 252
- Page 253
- Page 254
- Page 255
- Page 256
- Page 257
- Page 258
- Page 259
- Page 260
- Page 261
- Page 262
- Page 263
- Page 264
- Page 265
- Page 266
- Page 267
- Page 268
- Page 269
- Page 270
- Page 271
- Page 272
- Page 273
- Page 274
- Page 275
- Page 276
- Page 277
- Page 278
- Page 279
- Page 280
- Page 281
- Page 282
- Page 283
- Page 284
- Page 285
- Page 286
- Page 287
- Page 288
- Page 289
- Page 290
- Page 291
- Page 292
- Page 293
- Page 294
- Page 295
- Page 296
- Page 297
- Page 298
- Page 299
- Page 300
- Page 301
- Page 302
Not finding the right product?
Try our Product Selector Tool.
Polyclonal Antibodies
Polyclonal antibodies are generated by injecting an animal with an antigen of interest. After several weeks, the animal’s serum is collected and can either be used directly or subjected to further purification to isolate antibodies. Polyclonal antibodies often recognize multiple epitopes, making them more tolerant of small changes in the nature of the antigen.
Monoclonal Antibodies
Monoclonal antibodies are a laboratory-produced, homogeneous population of antibodies raised by the fusion of B cells with immortal cell cultures to produce hybridomas that can generate many copies of the exact same antibody. They recognize highly specific and unique epitopes with strong affinity and a reduced likelihood of cross-reactivity.
Recombinant Antibodies
Recombinant antibodies are monoclonal antibodies produced by cloning antibody genes into expression vectors, without the use of hybridomas. These antibodies can be cloned from any species using suitable oligonucleotide primers. This technology helps avoid issues such as cell-line drift and mutations associated with classical hybridoma production.
Explore more advantages of recombinant antibodies with our ZooMAb® Recombinant Monoclonal Antibodies.
Advantages and Disadvantages of Different Types of Primary Antibodies
| Recombinant | Monoclonal | Polyclonal | |
|---|---|---|---|
| Advantages |
|
|
|
| Disadvantages |
|
|
|
Conjugated Primary Antibodies
Conjugated primary antibodies are often used for signal amplification and detection without the use of a secondary antibody. A primary monoclonal or polyclonal antibody can be directly conjugated to fluorophores, enzymes, or biotin. Different antibody conjugates exhibit different stabilities and require specific buffers and storage conditions to maintain their maximal activity over time.
Primary Antibody Research Areas
Primary Antibodies for Cancer Research
Primary antibodies that detect abnormal proteins and tumor-associated antigens are valuable tools in cancer research. Some primary antibodies are used to block oncogenic pathways, stimulate antibody-dependent cellular cytotoxicity (ADCC), and activate complement-dependent cytotoxicity. These antibodies are crucial for studying tumor markers, tumor suppressors, invasion, metastasis, autophagy, apoptosis, and angiogenesis, offering insights into various aspects of cancer biology and treatment.
Find recombinant antibodies specifically targeting hallmarks of cancer on our Studying Hallmarks of Cancer with Recombinant Antibodies page.
Primary Antibodies for Neuroscience Research
Primary antibodies play a vital part in studying nervous system physiology and pathology by allowing researchers to identify and analyze specific proteins and cellular markers. They are essential for investigating synaptic biology, as well as understanding neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease. Additionally, these antibodies help explore neuroinflammation, which is a key factor in various neurological disorders.
Primary Antibodies for Epigenetic Research
Primary antibodies can also help explore the epigenetic processes that turn genes "on" and "off". DNA methylation and the post-translational modification of histones are among the major epigenetic factors.
Applications of Primary Antibodies
Primary antibodies are essential tools in a variety of laboratory techniques used to study proteins and their interactions. They enable precise detection, quantification, and analysis of specific proteins across different experimental techniques such as:
- ELISA: A plate-based assay technique designed for detecting and quantifying soluble substances. It combines the specificity of antibodies with the sensitivity of simple enzyme assays.
- Western Blotting: Detect specific protein molecules within a mixture of proteins.
- Immunocytochemistry: For visualization of proteins or other antigens in cells using antibodies specifically recognizing the target of interest.
- Immunohistochemistry: Selectively identify antigens (proteins) in cells of a tissue section.
- Immunoprecipitation: Precipitate a protein antigen out of solution using an antibody that specifically binds to that protein. This technique isolates and concentrates a protein from a sample containing many thousands of different proteins.
- Flow Cytometry: Detect and measure physical and chemical characteristics of a population of cells. Light scattering patterns are used to determine the size and intracellular complexity of cells.
- Affinity Binding Assay: Measure the strength of the binding interaction between a single antigen and antibody. A lower number indicates a higher binding affinity.
To continue reading please sign in or create an account.
Don't Have An Account?